Osteomyelitis of the tibial head caused by mycobacterium haemophilium in a patient with AIDS;Tibiakopf-osteomyelitis durch mycobacterium haemophilum bei einem patienten mit AIDS

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 38, 2002, Pages 1947-1950

  Gruschke, A ^a   Enzensberger, R ^a   Brade, V ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFABUTIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG INDICATION; HUMAN; MALE; MYCOBACTERIUM HAEMOPHILUM; OSTEOMYELITIS; SURGICAL WOUND; TIBIA; TREATMENT OUTCOME; WOUND HEALING;

ABSCESS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS; OFLOXACIN; OSTEOMYELITIS; RECURRENCE; RIFABUTIN; TIBIA;

EID: 0037144650     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34201     Document Type: Article

References (14)

1. Armstrong KL, James RW, Dawson DJ, Francis PW, Masters B. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr 1992; 121: 202-205
2. Atkinson BA, Bocanegra R, Graybill JR. Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin and ciprofloxacin. Antimicrob Agents Chemother 1995; 39: 2316-2319
3. Bachmann S, Schnyder U, Pfyffer GE, Lüthy R, Weber R. Mycobacterium-haemophilum - Infektion bei einem Patienten mit AIDS. Dtsch Med Wochenschr 1996; 121: 1189-1192
4. Dawson DJ, Jennis F. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol 1980; 11: 190-192
5. Dever LL, Martin JW, Seaworth B, Jorgensen JH. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis 1992; 14: 1195-1200
6. Hirsch R, Miller SM, Kazi S, Cate TR, Reveille JD. Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. Semin Arthritis Rheum 1996; 25: 347-356
7. Kristjansson M, Bieluch VM, Byeff PD. Mycobacterium haemophilum infection in immunocompromised patients: Case report and review of the literature. Rev Infect Dis 1991; 13: 906-910
8. Paech V, Lorenzen T, von Krosigk A et al. Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis 2002; 34: 1017-1019
9. Samra Z, Kaufmann L, Zeharia A et al. Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol 1999; 37: 832-34
10. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001; 33: 330-337
11. Sompolinsky D, Lagziel A, Naveh D, Yankilewitz T. Mycobacterium haemophilum sp. nov., a new pathogen of humans. In J syst Bacteriol 1978; 28: 67-75
12. Straus WL, Ostroff SM, Jernigan DB et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994; 120: 118-125
13. White DA, Kiehn TE, Bondoc AY, Massarella SA. Pulmonary nodule due to mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med 1999; 160: 1366-1368
14. Yarrish RL, Shay W, La Bombardi VJ, Meyerson M, Miller DK, Larone D. Osteomyelitis caused by Mycobacterium haemophilum: successful therapy in two patients with AIDS. AIDS 1992; 6: 557-561